Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri & Azarisman Shah Mohd Shah. (2019) Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings. Therapeutics and Clinical Risk Management 15, pages 137-145.
Read now
Read now
Kyriakos Souliotis, Christina Golna, Chara Kani & Sophia Markantonis. (2019) Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece. Expert Review of Pharmacoeconomics & Outcomes Research 19:5, pages 569-574.
Read now
Read now
Zorica Naumovska, Aleksandra K Nestorovska, Aleksandra Grozdanova, Kristina Hristova, Aleksandar Dimovski, Ljubica Suturkova & Zoran Sterjev. (2018) Evaluation of statin utilization in the Republic of Macedonia during 2013–2016. ClinicoEconomics and Outcomes Research 10, pages 339-347.
Read now
Read now
Axel Leporowski, Brian Godman, Amanj Kurdi, Sean MacBride-Stewart, Margaret Ryan, Simon Hurding, Renata CRM Do Nascimento, Marion Bennie & Alec Morton. (2018) Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 655-666.
Read now
Read now
R. C. R. M. do Nascimento, A. A. Guerra Jr.J. Alvares, I. C. Gomes, B. Godman, M. Bennie, A. B. Kurdi & F. A. de Acurcio. (2018) Statin use in Brazil: findings and implications. Current Medical Research and Opinion 34:10, pages 1809-1817.
Read now
Read now
Nikhil Khandelwal, Beverly Johns, Zsolt Hepp & Jane Castelli-Haley. (2018) The economic impact of switching from Synthroid for the treatment of hypothyroidism. Journal of Medical Economics 21:5, pages 518-524.
Read now
Read now
Joseph O. Fadare, Kazeem A. Oshikoya, Olayinka O. Ogunleye, Olufemi O. Desalu, Alessandra Ferrario, Okezie O. Enwere, Adekunle Adeoti, Taofiki A. Sunmonu, Amos Massele, Amanj Baker & Brian Godman. (2018) Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Hospital Practice 46:2, pages 77-87.
Read now
Read now
Vafa Abilova, Amanj Kurdi & Brian Godman. (2018) Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Review of Anti-infective Therapy 16:1, pages 77-84.
Read now
Read now
Loc Phuoc Thai, Agnes Isabelle Vitry & John Robert Moss. (2018) Price and utilisation differences for statins between four countries. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 71-81.
Read now
Read now
Brian Godman & Joseph Fadare. (2017) Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage. Current Medical Research and Opinion 33:11, pages 2085-2087.
Read now
Read now
Joseph O Fadare, Adekunle O. Adeoti, Olufemi O. Desalu, Okezie O. Enwere, Aliyu M. Makusidi, Olayinka Ogunleye, Taofiki A. Sunmonu, Ilse Truter, Onyinye O Akunne & Brian Godman. (2016) The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 639-650.
Read now
Read now
L. P. Thai, J. R. Moss, B. Godman & A. I. Vitry. (2016) Cost driver analysis of statin expenditure on Australia’s Pharmaceutical Benefits Scheme. Expert Review of Pharmacoeconomics & Outcomes Research 16:3, pages 419-433.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2015) Societal value of generic medicines beyond cost-saving through reduced prices. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 701-711.
Read now
Read now
Brian Godman, Iain Bishop, Stephen M Campbell, Rickard E Malmström & Ilse Truter. (2015) Quality and efficiency of statin prescribing across countries with a special focus on South Africa; findings and future implications. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 323-330.
Read now
Read now
Brian Godman, Rickard E Malmström, Eduardo Diogene, Andy Gray, Sisira Jayathissa, Angela Timoney, Francisco Acurcio, Ali Alkan, Anna Brzezinska, Anna Bucsics, Stephen M Campbell, Jadwiga Czeczot, Winnie de Bruyn, Irene Eriksson, Faridah Aryani Md Yusof, Alexander E Finlayson, Jurij Fürst, Kristina Garuoliene, Augusto Guerra Júnior, Jolanta Gulbinovič, Saira Jan, Roberta Joppi, Marija Kalaba, Einar Magnisson, Laura McCullagh, Kaisa Miikkulainen, Gabriela Ofierska-Sujkowska, Hanne Bak Pedersen, Gisbert Selke, Catherine Sermet, Susan Spillane, Azuwana Supian, Ilse Truter, Vera Vlahović-Palčevski, Low Ee Vien, Elif H Vural, Janet Wale, Magdałene Władysiuk, Wenjie Zeng & Lars L Gustafsson. (2015) Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?. Expert Review of Clinical Pharmacology 8:1, pages 77-94.
Read now
Read now
Wenjie Zeng, Lars L Gustafsson, Marion Bennie, Alexander E Finlayson & Brian Godman. (2015) Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 15:1, pages 157-169.
Read now
Read now
Jayashri Sankaranarayanan, Tom Reardon & Keith M Olsen. (2014) Correlates and economic outcomes of proton pump inhibitor use by routes in intensive care unit patients. Expert Review of Pharmacoeconomics & Outcomes Research 14:5, pages 741-749.
Read now
Read now
Pieter Dylst, Arnold G Vulto & Steven Simoens. (2014) Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability. Expert Review of Pharmacoeconomics & Outcomes Research 14:3, pages 345-353.
Read now
Read now
Panagiotis Petrou. (2014) The power of r – pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?. Expert Review of Pharmacoeconomics & Outcomes Research 14:2, pages 289-300.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now
Read now
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström. (2012) Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 809-819.
Read now
Read now
Vanda Markovic-Pekovic, Ranko Škrbić, Brian Godman & Lars L Gustafsson. (2012) Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 661-671.
Read now
Read now
Ljiljana Sovic Brkicic, Brian Godman, Luka Voncina, Slavica Sovic & Maja Relja. (2012) Initiatives to improve prescribing efficiency for drugs to treat Parkinson’s disease in Croatia: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 373-384.
Read now
Read now
Articles from other publishers (41)
Iris R. Joosse, David Tordrup, Julie Glanville, Eleanor Kotas, Aukje K. Mantel-Teeuwisse & Hendrika A. van den Ham. (2023) Evidence on the effectiveness of policies promoting price transparency - A systematic review. Health Policy 134, pages 104681.
Crossref
Crossref
Nataša Bednarčuk, Ana Golić Jelić, Svjetlana Stoisavljević Šatara, Nataša Stojaković, Vanda Marković Peković, Miloš P. Stojiljković, Nina Popović & Ranko Škrbić. (2023) Antibiotic Utilization during COVID-19: Are We Over-Prescribing?. Antibiotics 12:2, pages 308.
Crossref
Crossref
Che Suraya Zin, Nor Hidayah Taufek & Siti Halimah Bux. (2020) Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism. Frontiers in Public Health 8.
Crossref
Crossref
Yujuan Liu, Xian Zhu, Rongxin Li, Jun Zhang & Feng Zhang. (2020) Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open 10:11, pages e040473.
Crossref
Crossref
Pablo E. Gulayin, Alfredo Lozada, Andrea Beratarrechea, Laura Gutierrez, Rosana Poggio, Raúl Martín Chaparro, Marilina Santero, Walter Masson, Adolfo Rubinstein & Vilma Irazola. (2019) An Educational Intervention to Improve Statin Use: Cluster RCT at the Primary Care Level in Argentina. American Journal of Preventive Medicine 57:1, pages 95-105.
Crossref
Crossref
Brian Godman, Amanj Kurdi, Holly McCabe, Chris F Johnson, Corrado Barbui, Sean MacBride-Stewart, Simon Hurding, Axel Leporowski, Marion Bennie & Alec Morton. (2019) Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. Journal of Comparative Effectiveness Research 8:7, pages 535-547.
Crossref
Crossref
Niklas Bobrovitz, Carl Heneghan, Igho Onakpoya, Benjamin Fletcher, Dylan Collins, Alice Tompson, Joseph Lee, David Nunan, Rebecca Fisher, Brittney Scott, Jack O’Sullivan, Oliver Van Hecke, Brian D. Nicholson, Sarah Stevens, Nia Roberts & Kamal R. Mahtani. (2018) Medications that reduce emergency hospital admissions: an overview of systematic reviews and prioritisation of treatments. BMC Medicine 16:1.
Crossref
Crossref
Jaime Espin, Michael Schlander, Brian Godman, Pippa Anderson, Jorge Mestre-Ferrandiz, Isabelle Borget, Adam Hutchings, Steven Flostrand, Adam Parnaby & Claudio Jommi. (2018) Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates. Applied Health Economics and Health Policy 16:6, pages 803-817.
Crossref
Crossref
Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Ðermanović, Janja Bojanić, Jurij Fürst, Amanj B. Kurdi & Brian Godman. (2018) Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications. Frontiers in Pharmacology 9.
Crossref
Crossref
Claudia G. S. Osorio-de-Castro, Thiago B. Azeredo, Vera L. E. Pepe, Luciane C. Lopes, Sueli Yamauti, Brian Godman & Lars L. Gustafsson. (2018) Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?. Basic & Clinical Pharmacology & Toxicology 122:4, pages 402-412.
Crossref
Crossref
Stephen R. Chapman, Raymond W. Fitzpatrick & Mohammed I. Aladul. (2017) Has cost inhibited the uptake of more potent statins in England?. Pharmacoepidemiology and Drug Safety 26:8, pages 984-991.
Crossref
Crossref
Samantha Alvarez-Madrazo, Stuart McTaggart, Clifford Nangle, Elizabeth Nicholson & Marion Bennie. (2016) Data Resource Profile: The Scottish National Prescribing Information System (PIS). International Journal of Epidemiology 45:3, pages 714-715f.
Crossref
Crossref
Elisabetta Poluzzi, Giacomo Veronese, Carlo Piccinni, Emanuel Raschi, Ariola Koci, Paola Pagano, Brian Godman, Giulio Marchesini, Giuseppe Boriani & Fabrizio De Ponti. (2016) Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy. Basic & Clinical Pharmacology & Toxicology 118:1, pages 63-69.
Crossref
Crossref
Amanj Baker, Li-Chia Chen, Rachel A. Elliott & Brian Godman. (2015) The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design. BMC Health Services Research 15:1.
Crossref
Crossref
P. S. Nishtala & L. Soo. (2015) Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013. Internal Medicine Journal 45:6, pages 624-629.
Crossref
Crossref
Hye-Young Kwon, Bongmin Yang & Brian Godman. (2015) Key Components of Increased Drug Expenditure in South Korea: Implications for the Future. Value in Health Regional Issues 6, pages 14-21.
Crossref
Crossref
Marina Polić-Vižintin, Danijela Štimac, Zvonimir Šostar & Ingrid Tripković. (2014) Distribution and trends in outpatient utilization of generic versusbrand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Services Research 14:1.
Crossref
Crossref
James C. Moon, Brian Godman, Max Petzold, Samantha Alvarez-Madrazo, Kathleen Bennett, Iain Bishop, Anna Bucsics, Ulrik Hesse, Andrew Martin, Steven Simoens, Corinne Zara & Rickard E. Malmström. (2014) Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology 5.
Crossref
Crossref
Elisangela da Costa Lima-Dellamora, Rosângela Caetano, Lars L. Gustafsson, Brian B. Godman, Ken Patterson & Claudia Garcia Serpa Osorio-de-Castro. (2014) An Analytical Framework for Assessing Drug and Therapeutics Committee Structure and Work Processes in Tertiary Brazilian Hospitals. Basic & Clinical Pharmacology & Toxicology 115:3, pages 268-276.
Crossref
Crossref
Mohamed Azmi Hassali, Zhi Yen Wong, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review. Health Policy 117:3, pages 297-310.
Crossref
Crossref
Brian Godman, Bjorn Wettermark, Menno van Woerkom, Jessica Fraeyman, Samantha Alvarez-Madrazo, Christian Berg, Iain Bishop, Anna Bucsics, Stephen Campbell, Alexander E. Finlayson, Jurij Fürst, Kristina Garuoliene, Harald Herholz, Marija Kalaba, Ott Laius, Jutta Piessnegger, Catherine Sermet, Ulrich Schwabe, Vera V. Vlahović-PalÄevski, Vanda Markovic-Pekovic, Luka VonÄina, Kamila Malinowska, Corinne Zara & Lars L. Gustafsson. (2014) Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Frontiers in Pharmacology 5.
Crossref
Crossref
Ana Luísa Caires de Souza, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnior, Renata Cristina Rezende Macedo do Nascimento, Brian Godman & Leonardo Maurício Diniz. (2014) Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review. Applied Health Economics and Health Policy 12:1, pages 19-32.
Crossref
Crossref
Andrew Martin, Brian GodmanJamilette Miranda, Jeanette Tilstone, Nigget Saleem, Erika Olsson, Angela Acosta, Luis Restrepo & Marion Bennie. (2014) Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications. Journal of Comparative Effectiveness Research 3:1, pages 41-51.
Crossref
Crossref
Suzanne Dunne, Bill Shannon, Colum Dunne & Walter Cullen. (2013) A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology 14:1.
Crossref
Crossref
Brian Godman, Alexander E Finlayson, Parneet K Cheema, Eva Zebedin-Brandl, Inaki Gutiérrez-Ibarluzea, Jan Jones, Rickard E Malmström, Elina Asola, Christoph Baumgärtel, Marion Bennie, Iain Bishop, Anna Bucsics, Stephen Campbell, Eduardo Diogene, Alessandra Ferrario, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Katharine Harris, Alan Haycox, Harald Herholz, Krystyna Hviding, Saira Jan, Marija Kalaba, Christina Kvalheim, Ott Laius, Sven-Ake Lööv, Kamila Malinowska, Andrew Martin, Laura McCullagh, Fredrik Nilsson, Ken Paterson, Ulrich Schwabe, Gisbert Selke, Catherine Sermet, Steven Simoens, Dominik Tomek, Vera Vlahovic-Palcevski, Luka Voncina, Magdalena Wladysiuk, Menno van Woerkom, Durhane Wong-Rieger, Corrine Zara, Raghib Ali & Lars L Gustafsson. (2013) Personalizing health care: feasibility and future implications. BMC Medicine 11:1.
Crossref
Crossref
Wenjie Zeng. (2013) A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China. BMC Health Services Research 13:1.
Crossref
Crossref
Ulrik Hesse, Brian Godman, Max Petzold, Andrew Martin & Rickard E. Malmström. (2013) Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries. Applied Health Economics and Health Policy 11:6, pages 677-685.
Crossref
Crossref
Hye-Young Kwon, Ji-Min Hong, Brian Godman & Bong-Min Yang. (2013) Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents. Health Policy 112:3, pages 217-226.
Crossref
Crossref
Phill O’Neill, Jorge Mestre-Ferrandiz, Ruth Puig-Peiro & Jon Sussex. (2013) Projecting Expenditure on Medicines in the UK NHS. PharmacoEconomics 31:10, pages 933-957.
Crossref
Crossref
Pieter Dylst, Arnold Vulto, Brian Godman & Steven Simoens. (2013) Generic Medicines: Solutions for a Sustainable Drug Market?. Applied Health Economics and Health Policy 11:5, pages 437-443.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Corrado Barbui, Marion Bennie, Alexander E Finlayson, Emanuel Raschi & Bjorn Wettermark. (2013) Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications. Journal of Pharmaceutical Health Services Research 4:3, pages 139-150.
Crossref
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Crossref
B. Godman, B. Wettermark, J. Miranda, M. Bennie, A. Martin & R. E. Malmström. (2013) Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries. International Journal of Clinical Practice 67:9, pages 853-862.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref
Crossref
Susan E. Tett, Ingrid Sketris, Charmaine Cooke, Sander Veldhuyzen van Zanten & Nadia Barozzi. (2013) Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety 22:7, pages 735-743.
Crossref
Crossref
Sylvain Pichetti, Catherine Sermet, Brian Godman, Stephen M. Campbell & Lars L. Gustafsson. (2013) Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France. Applied Health Economics and Health Policy 11:3, pages 205-218.
Crossref
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Crossref
Brian Godman & Lars L. Gustafsson. (2013) A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy 11:1, pages 79-82.
Crossref
Crossref
Steven Simoens & Peter R. Sinnaeve. (2012) Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy. Cardiovascular Drugs and Therapy 27:1, pages 49-60.
Crossref
Crossref
Marija KalabaBrian Godman, Aleksandar Vuksanović, Marion Bennie & Richard E Malmström. (2012) Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?. Journal of Comparative Effectiveness Research 1:6, pages 539-549.
Crossref
Crossref
Menno van Woerkom, Hans Piepenbrink, Brian GodmanJoost de Metz, Stephen Campbell, Marion Bennie, Marietta Eimers & Lars L Gustafsson. (2012) Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1:6, pages 527-538.
Crossref
Crossref